Gordon Ramsay Blasts Ozempic Menus & Influencer Culture

Celebrity chef Gordon Ramsay has vehemently criticized the emerging trend of restaurants creating special menus for diners using weight loss medications like Ozempic and Mounjaro. In an interview with The Sunday Times, Ramsay dismissed the idea as “absolute bulls***,” stating his refusal to adapt his menus for what he calls the “Mounjaro jab.” He believes the core issue lies with diners' overeating, not a need for specialized, smaller portions to make them “feel like less of a fat f***.”

Ozempic and Mounjaro, initially developed for Type 2 diabetes treatment, have gained significant popularity for their weight-loss effects. These GLP-1 drugs work by mimicking hormones that regulate appetite and digestion, thereby suppressing hunger and slowing down the digestive process. This mechanism leaves users feeling fuller for longer periods, often reducing their desire for large meals.

Despite the drugs' widespread use, Ramsay, known for his direct approach to food, maintains that moderation is the key, not menu modifications. His stance starkly contrasts with fellow chef Heston Blumenthal, whose three-Michelin-starred restaurant, The Fat Duck, announced “The Mindful Experience,” a smaller-portion tasting menu specifically designed for individuals on GLP-1 weight loss drugs.

Beyond Ozempic menus, Ramsay also expressed his frustration with modern dining's “influencer culture,” particularly the prevalence of “f***ing ring lights” and constant photo-taking, especially among American diners. While acknowledging social media's role in restaurant promotion, he emphasized his disinterest in transforming his establishments into content studios. He explicitly stated that his newest London fine dining restaurant, Bonheur, would not be “flooded with TikTokers,” reinforcing his commitment to a traditional dining experience focused on flavor over digital display.

(Source: https://www.lifeandstylemag.com/posts/gordon-ramsay-calls-ozempic-restaurant-menus-absolute-bulls/)